A p53-regulated apoptotic gene signature predicts treatment response and outcome in pediatric acute lymphoblastic leukemia

References

• PuiCHEvansWETreatment of acute lymphoblastic leukemiaN Engl J Med200635416617816407512
   PubMed Web of Science ®Google Scholar
• PuiCHRellingMVDowningJRAcute lymphoblastic leukemiaN Engl J Med20043501535154815071128
   PubMed Web of Science ®Google Scholar
• HungerSPLuXDevidasMImproved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the children’s oncology groupJ Clin Oncol3016631669
   Web of Science ®Google Scholar
• HollemanACheokMHden BoerMLGene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatmentN Engl J Med200435153354215295046
   PubMed Web of Science ®Google Scholar
• BeesleyAHCummingsAJFreitasJRThe gene expression signature of relapse in paediatric acute lymphoblastic leukaemia: implications for mechanisms of therapy failureBr J Haematol200513144745616281934
   PubMed Web of Science ®Google Scholar
• KaspersGJVeermanAJPietersRIn vitro cellular drug resistance and prognosis in newly diagnosed childhood acute lymphoblastic leukemiaBlood199790272327299326239
   PubMed Web of Science ®Google Scholar
• LugthartSCheokMHden BoerMLIdentification of genes associated with chemotherapy cross resistance and treatment response in childhood acute lymphoblastic leukemiaCancer Cell2005737538615837626
   PubMed Web of Science ®Google Scholar
• PietersRHuismansDRLoonenAHRelation of cellular drug resistance to long-term clinical outcome in childhood acute lymphoblastic leukaemiaLancet19913383994031678081
   PubMed Web of Science ®Google Scholar
• YangJJBhojwaniDYangWGenome-wide copy number profiling reveals molecular evolution from diagnosis to relapse in childhood acute lymphoblastic leukemiaBlood20081124178418318768390
   PubMed Web of Science ®Google Scholar
• MullighanCGPhillipsLASuXGenomic analysis of the clonal origins of relapsed acute lymphoblastic leukemiaScience20083221377138019039135
   PubMed Web of Science ®Google Scholar
• HofJKrentzSvan SchewickCMutations and deletions of the TP53 gene predict nonresponse to treatment and poor outcome in first relapse of childhood acute lymphoblastic leukemiaJ Clin Oncol2011293185319321747090
   PubMed Web of Science ®Google Scholar
• KrentzSHofJMendiorozAPrognostic value of genetic alterations in children with first bone marrow relapse of childhood B-cell precursor acute lymphoblastic leukemiaLeukemia20132729530422699455
   PubMed Web of Science ®Google Scholar
• VogelsteinBLaneDLevineAJSurfing the p53 networkNature200040830731011099028
   PubMed Web of Science ®Google Scholar
• SchwartzJLJordanREvansHHCharacteristics of chromosome instability in the human lymphoblast cell line WTK1Cancer Genet Cytogenet200112912413011566342
   PubMedGoogle Scholar
• TsaiMHChenXChandramouliGVTranscriptional responses to ionizing radiation reveal that p53R2 protects against radiation-induced mutagenesis in human lymphoblastoid cellsOncogene20062562263216247478
   PubMed Web of Science ®Google Scholar
• LiCWongWHModel-based analysis of oligonucleotide arrays: expression index computation and outlier detectionProc Natl Acad Sci USA200198313611134512
   PubMed Web of Science ®Google Scholar
• PuiCHSandlundJTPeiDImproved outcome for children with acute lymphoblastic leukemia: results of Total Therapy Study XIIIB at St Jude Children’s Research HospitalBlood20041042690269615251979
   PubMed Web of Science ®Google Scholar
• PuiCHMahmoudHHRiveraGKEarly intensification of intrathecal chemotherapy virtually eliminates central nervous system relapse in children with acute lymphoblastic leukemiaBlood1998924114159657739
   PubMed Web of Science ®Google Scholar
• PuiCHCampanaDPeiDTreating childhood acute lymphoblastic leukemia without cranial irradiationN Engl J Med20093602730274119553647
   PubMed Web of Science ®Google Scholar
• BhojwaniDKangHMenezesRXGene expression signatures predictive of early response and outcome in high-risk childhood acute lymphoblastic leukemia: a Children’s Oncology Group Study [corrected]J Clin Oncol2008264376438418802149
   PubMed Web of Science ®Google Scholar
• MantelNHaenszelWStatistical aspects of the analysis of data from retrospective studies of diseaseJ Natl Cancer Inst19592271974813655060
   PubMed Web of Science ®Google Scholar
• KalbfleischJDPrenticeRLThe Statistical Analysis of Failure Time DataNew YorkJohn Wiley & Sons, Inc1988
   Google Scholar
• GrayRJA class of K-sample tests for comparing the cumulative incidence of a competing riskAnn Stat19881611411154
   Web of Science ®Google Scholar
• FineJPGrayRJA proportional hazards model for the subdistribution of a competing riskJASA199994496509
   Web of Science ®Google Scholar
• DumazNMilneDMJardineLJMeekDWCritical roles for the serine 20, but not the serine 15, phosphorylation site and for the polyproline domain in regulating p53 turnoverBiochem J200135945946411583595
   PubMed Web of Science ®Google Scholar
• MarstonEWestonVJessonJStratification of pediatric ALL by in vitro cellular responses to DNA double-strand breaks provides insight into the molecular mechanisms underlying clinical responseBlood200911311712618941120
   PubMed Web of Science ®Google Scholar
• Den BoerMLHarmsDOPietersRPatient stratification based on prednisolone-vincristine-asparaginase resistance profiles in children with acute lymphoblastic leukemiaJ Clin Oncol2003213262326812947061
   PubMed Web of Science ®Google Scholar
• ToledoFKrummelKALeeCJA mouse p53 mutant lacking the proline-rich domain rescues Mdm4 deficiency and provides insight into the Mdm2-Mdm4-p53 regulatory networkCancer Cell2006927328516616333
   PubMed Web of Science ®Google Scholar
• SchmittCAFridmanJSYangMBaranovEHoffmanRMLoweSWDissecting p53 tumor suppressor functions in vivoCancer Cell2002128929812086865
   PubMed Web of Science ®Google Scholar
• EischenCMRousselMFKorsmeyerSJClevelandJLBax loss impairs Myc-induced apoptosis and circumvents the selection of p53 mutations during Myc-mediated lymphomagenesisMol Cell Biol2001217653766211604501
   PubMed Web of Science ®Google Scholar
• VousdenKHLaneDPp53 in health and diseaseNat Rev Mol Cell Biol2007827528317380161
   PubMed Web of Science ®Google Scholar
• PolyakKXiaYZweierJLKinzlerKWVogelsteinBA model for p53-induced apoptosisNature19973893003059305847
   PubMed Web of Science ®Google Scholar
• LuXMaONguyenTAJonesSNOrenMDonehowerLAThe Wip1 phosphatase acts as a gatekeeper in the p53-Mdm2 autoregulatory loopCancer Cell20071234235417936559
   PubMed Web of Science ®Google Scholar
• TamuraREde VasconcellosJFSarkarDGADD45 proteins: central players in tumorigenesisCurr Mol Med20121263465122515981
   PubMed Web of Science ®Google Scholar
• CazzaliniOScovassiAISavioMMultiple roles of the cell cycle inhibitor p21(CDKN1A) in the DNA damage responseMutat Res2010704122020096807
   PubMed Web of Science ®Google Scholar
• BersaniCXuLDVilborgAWig-1 regulates cell cycle arrest and cell death through the p53 targets FAS and 14-3-3σOncogene2014334407441724469038
   PubMed Web of Science ®Google Scholar
• HatakeyamaSTRIM proteins and cancerNat Rev Cancer20111179280421979307
   PubMed Web of Science ®Google Scholar